SPRUCE BIOSCIENCES, INC. filed a Form D with the Securities and Exchange Commission on 2025-10-17.
SPRUCE BIOSCIENCES, INC. filed a Form D notice of an exempt securities offering with the SEC on October 17, 2025. The filing reports $50M sold. Its industry group is Biotechnology. It names Javier Szwarcberg (Executive Officer, Director), Bali Muralidhar (Director), Daniel Spiegelman (Director) (SEC Form D, October 17, 2025).
Is this your company?
Sell to companies like SPRUCE BIOSCIENCES, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SPRUCE BIOSCIENCES, INC.
Free to see. No signup.
More on the people and the money behind SPRUCE BIOSCIENCES, INC., from the filings we hold.
H.C. Wainwright & Co., LLC received sales compensation on this raise and on 19 other raises we hold, nearest in date first:
Leerink Partners LLC received sales compensation on this raise and on 10 other raises we hold, nearest in date first:
Biotechnology raises by companies based in California, filed in October 2025, largest first.
Get an email when SPRUCE BIOSCIENCES, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SPRUCE BIOSCIENCES, INC. raises, hires or launches. No email unless you switch it on.
Watch SPRUCE BIOSCIENCES, INC. →Get the full cited report on SPRUCE BIOSCIENCES, INC.
What the filing shows about SPRUCE BIOSCIENCES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on SPRUCE BIOSCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SPRUCE BIOSCIENCES, INC.'s address as 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on SPRUCE BIOSCIENCES, INC. See pricing
SPRUCE BIOSCIENCES, INC. is a registered filer with the SEC (CIK 1683553) and has filed since 2023-02-28. 2 filings are on record, the latest on 2025-10-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SPRUCE BIOSCIENCES, INC.'s Form D of 2025-10-17 names Javier Szwarcberg, Bali Muralidhar, Daniel Spiegelman and 6 more as its officers, directors or promoters.
Its new offerings report $103.62M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
The Company shall use the net proceeds of the sale of the Securities hereunder for non-clinical and clinical development activities for its product candidate, pre-commercial activities and general corporate purposes.
Checked away from the filing. What is below does not come from the record on sec.gov.
Spruce is committed to advancing meaningful therapies for underserved neurological conditions like MPS IIIB (Sanfilippo Syndrome Type B). Our investigational therapy, TA-ERT, is guided by science, empathy, and patient voices to deliver urgently needed outcomes that transform lives.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Javier Szwarcberg is named as Executive Officer and Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Bali Muralidhar is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Daniel Spiegelman is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Michael Grey is named as Executive Officer and Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Simpson Camilla is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Tiba Aynechi is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Kirk Ways is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Samir Gharib is named as Executive Officer on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
Percival Barretto-Ko is named as Director on the Form D that SPRUCE BIOSCIENCES, INC. filed with the SEC on 17 October 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-10-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SPRUCE BIOSCIENCES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on SPRUCE BIOSCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SPRUCE BIOSCIENCES, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SPRUCE BIOSCIENCES, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind SPRUCE BIOSCIENCES, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (sprucebio.com).
Each opens in a new tab, filled in for SPRUCE BIOSCIENCES, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/spruce-biosciences-inc-form-d-25000001